60295-0101 NDC - ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS

Drug Information

  • Product NDC: 60295-0101
  • Proprietary Name:
  • Non Proprietary Name: ECHINACEA ANGUSTIFOLIA, HAMAMMELIS VIRGINIANA, CALCAREA PHOSPHORICA, HYDRASTIS CANADANESIS, SENEGA OFFICINALIS, SILICEA, CONIUM, AURUM MURIATICUM NATRONATUM, CALCAREA CARBONICA, FUCUS VESICULOSUS, LACHESIS MUTUS
  • Active Ingredient(s): 4 [hp_X]/1 CONIUM MACULATUM FLOWERING TOP; 1 [hp_X]/1 ECHINACEA ANGUSTIFOLIA; 5 [hp_X]/1 FUCUS VESICULOSUS; 4 [hp_X]/1 GOLDENSEAL; 2 [hp_X]/1 HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; 8 [hp_X]/1 LACHESIS MUTA VENOM; 5 [hp_X]/1 OYSTER SHELL CALCIUM CARBONATE, CRUDE; 4 [hp_X]/1 POLYGALA SENEGA ROOT; 4 [hp_X]/1 SILICON DIOXIDE; 5 [hp_X]/1 SODIUM TETRACHLOROAURATE; 3 [hp_X]/1 TRIBASIC CALCIUM PHOSPHATE
  • Administration Route(s):
  • Dosage Form(s): TABLET, ORALLY DISINTEGRATING

Labeler Information

Field Name Field Value
Labeler Name: Nestmann Pharma GmbH
Product Type: DRUG FOR FURTHER PROCESSING
FDA Application Number:
Marketing Category: DRUG FOR FURTHER PROCESSING
Start Marketing Date:3/1/1992
End Marketing Date:12/27/2022

Package Information

No. Package Code Package Description Billing Unit
160295-0101-325000 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER (60295-0101-3)
260295-0101-425000 TABLET, ORALLY DISINTEGRATING in 1 DRUM (60295-0101-4)

NDC Record

Field Name Field Value Definition
PRODUCT NDC60295-0101The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE3/1/1992This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENestmann Pharma GmbHName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC60295-0101The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
START MARKETING DATE3/1/1992This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEDRUG FOR FURTHER PROCESSINGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENestmann Pharma GmbHName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/19/2025

Previous Code
Next Code